Algernon Health Inc.

Research Algernon Health Inc. (AGW2) on Bullrun: market cap EUR 1.26M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAGW2
• ExchangeF
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 1.26M
• Financial periodQ4 2025
• Net income-EUR 597.01K
• Free cash flow-EUR 356.91K

Valuation Snapshot

latest market cap is EUR 1.26M.

About Algernon Health Inc.

Algernon Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Pharmaceuticals Inc.

Frequently asked questions

What is Algernon Health Inc.'s market cap?

Algernon Health Inc.'s market capitalization is EUR 1.26M.

What does Algernon Health Inc. do?

Algernon Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program.